Clinical Trial: This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenstrom's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07160270) titled 'This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenstrom's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process' on June 02.

Brief Summary: Neuropathy severely reduces patients' quality of life due to sensory loss, chronic neuropathic pain, and loss of mobility of arms and legs. Given the diverse origins of neuropathy, it is critical to identify its specific causes, particularly when effective treatments are available. Neuropathy is a frequent morbidity in Waldenstrom's macroglobulinemia (WM), a specific type ...